• Annual Conference 2026
  • Single Topic Workshop 2026
  • Past Events

Search

How Can We Help?

Contact Us
  • Annual Conference 2026
  • Single Topic Workshop 2026
  • Past Events
Contact Us
  • Annual Conference 2026
  • Single Topic Workshop 2026
  • Past Events

Search

How Can We Help?

  • Annual Conference 2026
  • Single Topic Workshop 2026
  • Past Events

ILCA Annual Conference 2026 Scientific
Programme
Register at Early Bird Rate 3-5 September 2026 | Brussels, Belgium
Home
Registration
Programme - Open call for abstracts

ILCA Annual Conference

Message from the Programme Committee Chair

This year’s programme brings together the most clinically and scientifically relevant topics in primary liver cancer, covering everything from basic and translational research to evidence‑based management of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Our line‑up of speakers will share the latest advances in surveillance, diagnostics, treatment strategies, and survivorship across the entire disease spectrum.
You can expect an international, multidisciplinary faculty who will not only deliver comprehensive presentations but also lead meaningful discussions aimed at deepening scientific understanding, improving clinical practice, and highlighting unmet needs in the field. Sessions will be highly interactive and designed to encourage open, thoughtful dialogue on current controversies, methodological challenges, and future research directions in liver cancer
Join us in Brussels
Amit Singal
ILCA Annual Conference 2026, Programme Committee Chair

Open Call for Abstracts

Do you want to be
part of the ILCA
programme?

Open until 13 April 2026.
Submit your abstract
The call for abstract for the ILCA Annual Conference 2026 is now open! If you’re eager to be part of the programme, contribute with your ideas and latest advances explore the topics under which you can submit your abstract and join is in Brussels to present your latest insights.

 

This year’s topics:
  • Molecular Pathogenesis, Cell Biology, and Translational Research
  • Epidemiology, Staging, and Prognosis
  • Diagnosis, Imaging and Biomarkers
  • Therapy & Miscellaneous
  • Clinical Trials in progress (Posters only)

Meet #ILCA26 Programme Committee

Amit Singal

[University of Texas Southwestern Medical Center, USA]

Jesper Andersen

[University of Copenhagen, Denmark]

Julius Chapiro

[Yale University School of Medicine, USA]

Valerie Chew

[A*STAR Singapore; Translational Immunology Institute (TII); Duke-NUS Medical School, Singapore]

Hong Jae Chon

[CHA Bundang Medical Center, CHA University, South Korea]

Tim Greten

[National Cancer Institute (USA), National Institutes of Health, USA]

Ashish Kumar

[Sir Ganga Ram Hospital, India]

Anja Lachenmayer

[University Hospital Bern, Bern, Switzerland]

Robert J Lewandowski

[Northwestern University; Robert H. Lurie Comprehensive Cancer Center, USA]

Josep M Llovet

[Icahn School of Medicine at Mount Sinai; IDIBAPS–Hospital Clínic; University of Barcelona, Spain]

Grainne O’Kane

[St. Vincents' University Hospital and University College Dublin, Ireland]

Federico Piñero

[Hospital Universitario Austral, Austral University, Argentina]

Pil Soo Sung

[The Catholic University of Korea, Seoul St. Mary's Hospital, South Korea]

Bachir Taouli

[Icahn School of Medicine at Mount Sinai, USA]

Nguyen H Tran

[Mayo Clinic, Rochester MN, USA]

Georgios Tsoulfas

[Aristotle University of Thessaloniki School of Medicine, Greece]

Carmen Wong

[University of Hong Kong (HKU), Hong Kong]

Qinghe Zeng

[University Hospital Heidelberg, Germany]

ILCA Live | All Rights Reserved © 2025 | Privacy Policy

ILCA Live | All Rights Reserved © 2025 | Privacy Policy

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}